Clinical studies show that GLP-1 receptor sensitivity declines gradually over 12-24 months, and weight loss velocity naturally decreases as you approach a new metabolic set point
I almost got fired from the first show I ever was on, where I was the star of the show
Los participantes del ensayo clnico que tomaron tirzepatida, el medicamento vendido como Zepbound, perdieron 22,8 kilogramos (50 libras) en promedio durante 72 semanas, mientras que aquellos que tomaron semaglutida, o Wegovy, perdieron alrededor de 15 kilos (33 libras), de acuerdo con el estudio financiado por Lilly y que fue publicado en el New England Journal of Medicine
That set the stage for Wegovy, which was approved in June 2021 as the first high-dose semaglutide specifically for weight management
Keeping these timelines straight is key to getting the full benefit of your medication